Eesti - eesti - Ravimiamet

sandoz pharmaceuticals d.d. - fingolimood - kõvakapsel - 0,5mg 98tk; 0,5mg 28tk; 0,5mg 7tk

Eesti - eesti - Ravimiamet

gedeon richter plc. - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 98tk; 0,5mg 28tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

mylan ireland limited - fingolimod vesinikkloriid - sclerosis multiplex, relapsing-remitting - immunosupressandid - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ja 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Eesti - eesti - Ravimiamet

accord healthcare b.v. - karmustiin - infusioonilahuse kontsentraadi pulber ja lahusti - 100mg 10tk; 100mg 1tk

Eesti - eesti - Adama

adama - graanulid - metaldehüüd - molluskitsiidid

Eesti - eesti - Ravimiamet

teva gmbh - pirfenidoon - õhukese polümeerikattega tablett - 801mg 252tk; 801mg 84tk

Eesti - eesti - Ravimiamet

stada arzneimittel ag - fingolimood - kõvakapsel - 0,5mg 7tk; 0,5mg 28tk; 0,5mg 30tk

Eesti - eesti - Ravimiamet

teva gmbh - pirfenidoon - õhukese polümeerikattega tablett - 267mg 252tk

Eesti - eesti - Ravimiamet

zentiva k.s. - pirfenidoon - õhukese polümeerikattega tablett - 801mg 252tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

axunio pharma gmbh - pirfenidone - idiopaatiline kopsufibroos - immunosupressandid - pirfenidone aet is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).